Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy

Yanjun Zheng1,2, Shanshan Gu1, Xuxia Li1

  • 1Key Laboratory of Stem Cell Biology and Laboratory of Molecular Cardiology, Institute of Health Sciences, Shanghai Jiao Tong University School of Medicine & Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

Cell Death & Disease
|February 3, 2017
PubMed

Insights

Berbamine postconditioning protects the heart from ischemia/reperfusion injury by modulating autophagy. This process restores autophagic flux and improves cardiac function, offering a potential therapeutic strategy.

Area of Science:

  • Cardiovascular Physiology
  • Cellular Biology
  • Pharmacology

Background:

  • Ischemia/reperfusion (I/R) injury is a major cause of heart damage.
  • Autophagy is upregulated in I/R myocardium and can exacerbate cardiomyocyte death.
  • Berbamine pretreatment shows cardioprotective effects, but its role during reperfusion is unclear.

Purpose of the Study:

  • To investigate the cardioprotective effects of berbamine given at the onset of reperfusion (postconditioning).
  • To determine if berbamine postconditioning (BMPoC) modulates autophagy during I/R injury.
  • To elucidate the signaling pathways involved in BMPoC-mediated cardioprotection.

Main Methods:

  • Perfused rat hearts and isolated cardiomyocytes subjected to I/R were treated with varying concentrations of berbamine.
  • Infarct size, cell death, and functional recovery were assessed.
  • Autophagy markers (LC3-II, p62, Beclin 1), autophagic flux, and the PI3K/Akt pathway were analyzed.

Main Results:

  • BMPoC concentration-dependently improved post-ischemic myocardial function and reduced cell death.
  • BMPoC prevented I/R-induced impairment of autophagosome processing and restored autophagic flux.
  • BMPoC inhibited Beclin 1 expression and its cardioprotection was dependent on PI3K/Akt signaling.

Conclusions:

  • Berbamine postconditioning confers significant cardioprotection against I/R injury.
  • BMPoC protects the heart by modulating autophagy during reperfusion, restoring autophagic flux.
  • The cardioprotective effects of BMPoC are mediated through the activation of the PI3K/Akt signaling pathway.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K